HCM
MLNT

Highbridge Capital Management’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Highbridge Capital Management’s Portfolio MLNT Stock Details MLNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,924
Closed -$108K – 1049
2018
Q1 		$108K Buy
+2,924
New +$108K ﹤0.01% 685